Senseonics, Beta Bionics Partner on Eversense 365-iLet Diabetes System
MT newswire2026/09/14 11:48Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
07:48 AM EDT, 09/14/2026 (MT Newswires) -- Senseonics (SENS) has partnered with Beta Bionics (BBNX) to integrate its Eversense 365 continuous glucose monitoring system with the iLet Bionic Pancreas automated insulin delivery system, the company said Monday. The companies plan to combine Eversense 365's year-long glucose sensing with iLet's adaptive insulin delivery, without requiring users to count carbohydrates. Senseonics expects the integration to be completed in Q4, with a commercial launch planned for the quarter, it added. Senseonics shares rose 1.3% in premarket trading while Beta Bionics shares fell 3%.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambium Networks UK unit enters administration in England, Wales
Reuters•2026/09/14 12:37
Market Chatter: OpenAI's Altman Says No IPO This Year
MT newswire•2026/09/14 12:37
Moleculin Biotech says AACR pancreatic cancer conference features new Annamycin trial data
Reuters•2026/09/14 12:35
Bowman Consulting Ends Go-Shop Period With no Competing Offers
MT newswire•2026/09/14 12:35
